Literature DB >> 15470384

Duchenne muscular dystrophy and dystrophin: pathogenesis and opportunities for treatment.

Kristen J Nowak1, Kay E Davies.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15470384      PMCID： PMC1299132          DOI： 10.1038/sj.embor.7400221

Source DB:  PubMed          Journal:  EMBO Rep        ISSN： 1469-221X            Impact factor:   8.807


× No keyword cloud information.
  51 in total

1.  The spread of transgene expression at the site of gene construct injection.

Authors:  A J O'Hara; J M Howell; R H Taplin; S Fletcher; F Lloyd; B Kakulas; H Lochmüller; G Karpati
Journal:  Muscle Nerve       Date:  2001-04       Impact factor: 3.217

2.  Muscular nitric oxide synthase (muNOS) and utrophin.

Authors:  Emmanuel Chaubourt; Vincent Voisin; Philippe Fossier; Gérard Baux; Maurice Israël; Sabine De La Porte
Journal:  J Physiol Paris       Date:  2002 Jan-Mar

3.  Transfer of full-length Dmd to the diaphragm muscle of Dmd(mdx/mdx) mice through systemic administration of plasmid DNA.

Authors:  F Liu; M Nishikawa; P R Clemens; L Huang
Journal:  Mol Ther       Date:  2001-07       Impact factor: 11.454

Review 4.  Function and genetics of dystrophin and dystrophin-related proteins in muscle.

Authors:  Derek J Blake; Andrew Weir; Sarah E Newey; Kay E Davies
Journal:  Physiol Rev       Date:  2002-04       Impact factor: 37.312

Review 5.  Developments in gene therapy for muscular dystrophy.

Authors:  D Hartigan-O'Connor; J S Chamberlain
Journal:  Microsc Res Tech       Date:  2000 Feb 1-15       Impact factor: 2.769

Review 6.  Molecular pathophysiology and targeted therapeutics for muscular dystrophy.

Authors:  E P Hoffman; D Dressman
Journal:  Trends Pharmacol Sci       Date:  2001-09       Impact factor: 14.819

7.  In vivo and in vitro correction of the mdx dystrophin gene nonsense mutation by short-fragment homologous replacement.

Authors:  R Kapsa; A Quigley; G S Lynch; K Steeper; A J Kornberg; P Gregorevic; L Austin; E Byrne
Journal:  Hum Gene Ther       Date:  2001-04-10       Impact factor: 5.695

8.  Dystrophin expression in myofibers of Duchenne muscular dystrophy patients following intramuscular injections of normal myogenic cells.

Authors:  Daniel Skuk; Brigitte Roy; Marlyne Goulet; Pierre Chapdelaine; Jean-Pierre Bouchard; Raynald Roy; Francine J Dugré; Jean-Guy Lachance; Louise Deschênes; Senay Hélène; Michel Sylvain; Jacques P Tremblay
Journal:  Mol Ther       Date:  2004-03       Impact factor: 11.454

9.  Intraarterial injection of muscle-derived CD34(+)Sca-1(+) stem cells restores dystrophin in mdx mice.

Authors:  Y Torrente; J P Tremblay; F Pisati; M Belicchi; B Rossi; M Sironi; F Fortunato; M El Fahime; M G D'Angelo; N J Caron; G Constantin; D Paulin; G Scarlato; N Bresolin
Journal:  J Cell Biol       Date:  2001-01-22       Impact factor: 10.539

10.  A nitric oxide synthase transgene ameliorates muscular dystrophy in mdx mice.

Authors:  M Wehling; M J Spencer; J G Tidball
Journal:  J Cell Biol       Date:  2001-10-01       Impact factor: 10.539
View more
  92 in total

1.  The GTPase RhoA increases utrophin expression and stability, as well as its localization at the plasma membrane.

Authors:  Armelle Bonet-Kerrache; Mathieu Fortier; Franck Comunale; Cécile Gauthier-Rouvière
Journal:  Biochem J       Date:  2005-10-15       Impact factor: 3.857

Review 2.  Sarcolipin: A Key Thermogenic and Metabolic Regulator in Skeletal Muscle.

Authors:  Meghna Pant; Naresh C Bal; Muthu Periasamy
Journal:  Trends Endocrinol Metab       Date:  2016-09-13       Impact factor: 12.015

3.  Increased catalase expression improves muscle function in mdx mice.

Authors:  Joshua T Selsby
Journal:  Exp Physiol       Date:  2010-11-01       Impact factor: 2.969

4.  Biomechanics of the sarcolemma and costameres in single skeletal muscle fibers from normal and dystrophin-null mice.

Authors:  K P García-Pelagio; R J Bloch; A Ortega; H González-Serratos
Journal:  J Muscle Res Cell Motil       Date:  2011-02-11       Impact factor: 2.698

5.  Laminin-111 protein therapy enhances muscle regeneration and repair in the GRMD dog model of Duchenne muscular dystrophy.

Authors:  Pamela Barraza-Flores; Tatiana M Fontelonga; Ryan D Wuebbles; Hailey J Hermann; Andreia M Nunes; Joe N Kornegay; Dean J Burkin
Journal:  Hum Mol Genet       Date:  2019-08-15       Impact factor: 6.150

Review 6.  Gene Therapy for Heart Failure: New Perspectives.

Authors:  Khatia Gabisonia; Fabio A Recchia
Journal:  Curr Heart Fail Rep       Date:  2018-12

7.  A new method of genotyping MDX4CV mice by PCR-RFLP analysis.

Authors:  Elisia D Tichy; Foteini Mourkioti
Journal:  Muscle Nerve       Date:  2017-03-21       Impact factor: 3.217

Review 8.  Function and regulation of microRNA-31 in development and disease.

Authors:  Nadezda A Stepicheva; Jia L Song
Journal:  Mol Reprod Dev       Date:  2016-08-02       Impact factor: 2.609

9.  Identifying set-wise differential co-expression in gene expression microarray data.

Authors:  Sung Bum Cho; Jihun Kim; Ju Han Kim
Journal:  BMC Bioinformatics       Date:  2009-04-16       Impact factor: 3.169

10.  Rescue of skeletal muscle alpha-actin-null mice by cardiac (fetal) alpha-actin.

Authors:  Kristen J Nowak; Gianina Ravenscroft; Connie Jackaman; Aleksandra Filipovska; Stefan M Davies; Esther M Lim; Sarah E Squire; Allyson C Potter; Elizabeth Baker; Sophie Clément; Caroline A Sewry; Victoria Fabian; Kelly Crawford; James L Lessard; Lisa M Griffiths; John M Papadimitriou; Yun Shen; Grant Morahan; Anthony J Bakker; Kay E Davies; Nigel G Laing
Journal:  J Cell Biol       Date:  2009-05-25       Impact factor: 10.539
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.